Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03286608
Other study ID # Three-City study Bordeaux
Secondary ID
Status Completed
Phase N/A
First received September 14, 2017
Last updated September 14, 2017
Start date January 1, 1999
Est. completion date December 31, 2015

Study information

Verified date September 2017
Source University of Bordeaux
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This project aims to leverage existing data from a large observational prospective study on dementia, the Three-City study, to investigate the relationship between intakes of polyphenols and the risk to develop dementia in the 12 years following dietary assessment.


Description:

The study sample includes 1,329 subjects followed for up to 12 years fro dementia after dietary assessment. The aim is to identify a pattern of polyphenol intake (based on 26 flavonoid and non-flavonoid polyphenol subclasses ascertained using a 24-hour dietary recall) associated with the risk of dementia and AD over 12 years in the 3C Bordeaux cohort.


Recruitment information / eligibility

Status Completed
Enrollment 1329
Est. completion date December 31, 2015
Est. primary completion date December 31, 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria:

- 65 years or more, live in Bordeaux area (France)

Exclusion Criteria:

- with dementia at the time of dietary assessment in year 2001-2002

Study Design


Related Conditions & MeSH terms


Intervention

Other:
observational study (no intervention)
Statistical association between adherence to a pattern of polyphenol intake and the risk to develop dementia and Alzheimer's disease over 12 years

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Jean-François Dartigues

Outcome

Type Measure Description Time frame Safety issue
Primary incidence of dementia incident cases of dementia diagnosed by the expert committee of neurologists at follow-up visits 12 years
Secondary incidence of Alzheimer's disease dementia with probable or possible Alzheimer etiology 12 years